Abramson Cancer Center hematologic malignancies’ clinicians and researchers have led the way nationally for years; both in the care of patients with hematologic malignancies (blood cancer) and in its research.
Today, there's more hope than ever for those who face a blood cancer diagnosis.
Penn’s program is one of the oldest and largest in the country. By putting our experience to work, we offer the best possible treatment outcomes.
Penn has one of the few Hematologic Malignancy (leukemia, lymphoma and myeloma) Research Programs in the country that is approved and funded by the National Cancer Institute. It is through this research program that Penn has made significant advances in improving bone marrow and stem cell transplants and the care of patients with blood cancer.
The knowledge gained through our research allows us to better care for those with blood cancers.
To learn about what sets us apart, visit:
Battling Cancer While Pregnant
Jeanie, an 8th grade Spanish teacher at Spring Ford Eighth Grade Center, and her husband Phil, a senior manager at Vanguard, absolutely love their jobs and had been happily married for 14 years.
After almost 12 years of trying to have children, they were thrilled to find out that Jeanie was pregnant. We couldn't believe it!" says Jeanie. "And then to find out we were having twins girls was the biggest blessing we could have asked for. My heart was melting."
But at only 15 weeks, fear and shock set in when Jeanie felt a lump in her breast and was diagnosed with stage II invasive breast cancer. "We are going to approach this head on. I just kept thinking about my girls, and how I wanted to get through this, and so I went to see the best," says Jeanie.
Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.